M8 Pharmaceuticalsa Subsidiary Of Acinois A Specialty Biopharmaceutical Company Focused On Delivering Innovative Medicines To Latin Americathe Company Forms Strategic Partnerships With Global Pharmaceutical Firms To Support The Developmentcommercializationand Distribution Of Original Therapies In The Region M8 Pharmaceuticals Offers A Range Of Services To Assist Pharmaceutical Companies In Entering And Growing Their Presence In The Latin American Marketthese Services Include Licensing And Commercializationmarket Entry And Compliancesales And Marketing Managementand Market Optimizationthe Company Has Established Exclusive Licensing Agreements For Notable Productsincluding Qelbree For Adhd And Voraxaze For Cancer Treatmentand Is Also Involved In Introducing Novel Treatments For Type 2 Diabetes And Osteoarthritis Headquartered In Pennsylvaniam8 Pharmaceuticals Employs Between 201 And 500 People And Utilizes Various Technology Platforms To Enhance Its Operationsthe Company Is Dedicated To Ensuring Patients In Latin America Have Access To Effective Medicines While Upholding High Standards Of Integrity And Ethical Practices In All Its Partnerships
